Trial Profile
Aldosterone-renin ratio to diagnose primary aldosteronism in a population of patients with therapy-resistant hypertension: Test characteristics, diagnostic value and predictive value for antihypertensive treatment. The Dutch ARRAT study
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Eplerenone (Primary)
- Indications Hyperaldosteronism; Hypertension
- Focus Therapeutic Use
- Acronyms Dutch ARRAT Study
- 29 Dec 2006 New trial record.